Resources Reinvest or Reallocate? A Capital Guide for Profitable Clinic Owners. By Medinex Specialist Centre Team Sept 15, 2026 By Medinex Team Building a profitable private medical practice in Singapore is a remarkable achievement given the high cost of operation and sti competition. Once your practice reaches stable operational maturity and generates significant free cash flow, a strategic question arises: What is the most effective way to deploy the accumulated profits? Strategic capital allocation is a defining skill for physician-entrepreneurs. Leaving your excess Strategic capital allocation is a defining skill for physician-entrepreneurs. Leaving your excess retained earnings idle in corporate bank accounts exposes the capital to inflationary erosion while you miss out on growth opportunities. Conversely, hasty deployment without a structured framework can subject your practice to unwarranted risks and result in instability. As Singapore’s private practice owners, you can generally consider three primary pathways for profit deployment: • Expanding the core enterprise organically to multi-clinic footprints.• De-risking and monetising equity through group consolidation and mergers.• Diversifying into adjacent commercial assets. Each path carries distinct implications for operational control, equity value, and long-term exit strategy. Let’s explore each option to gain a clearer understanding of the Pros and Cons. 1. Reinvestment to Fuel Organic Footprint Expansion Scaling the existing practice by expanding the number of clinic outlets and recruiting doctors represents a direct growth path. Reinvesting your profits into expanding the physical and clinical footprint leverages your established clinical workflows, patient goodwill, and brand reputation. However, it is important to have a clear idea of how to structure the equity when recruiting new associates to ensure good operational control and business risk management. Equity Structuring and Earn-In Mechanisms A common pitfall in multi-clinic expansion is offering equity prematurely or under terms that dilute operational control. To mitigate equity risk while aligning incentives, you can consider the following two practices: Tiered Earn-In Models: Instead of granting immediate equity upon recruitment, you can implement a structured 3-to-5-year earn-in timeline where associate doctors can purchase equity at pre-agreed valuation multiples contingent on meeting clinical billing targets, patient retention metrics, and other business or cultural criteria. Dual-Class Share Structures1–4: The legislative framework under the Singapore Companies Act 19675 (specifically section 64, as amended by the Companies (Amendment) Act 2014) permits both private and public companies incorporated in Singapore to issue multiple classes of shares with different voting rights (e.g., multiple-vote shares, non-voting shares, or conditional voting shares). When doing this, you should also seek legal advice to ensure compliance with applicable licensing, governance and regulatory requirements under the Healthcare Services Act6 and any relevant licensing conditions. Payout based on Clinical Contributions vs Dividend Distribution Having a clear, transparent profit distribution model prevents disputes between senior founders and junior partners. You may consider adopting a balanced two-tier framework that separates clinical contributions from capital ownership: Clinical Contributions: Allocate a percentage of net profit generated directly from an individual doctor’s personal billings (after deducting direct material costs and allocated overheads). Dividend Distribution7–8: Equity Dividend Distribution (Tier 2): Distribute residual corporate profits solely based on shareholding percentages. Additionally, you should also set a mandatory Retained Earnings Reserve Rule that mandates retaining a fixed percentage (e.g., 20% to 30%) of net annual profits within the corporate entity to fund future capital expenditures (CapEx) and maintain operational buers before releasing the earnings as dividends. 2. Group Consolidation—Unlocking Liquidity via M&A As healthcare consolidation accelerates in Southeast Asia, private equity-backed groups and listed medical corporates are actively acquiring independent practices in Singapore. Joining a larger clinic group converts illiquid practice equity into cash and liquid shares while outsourcing administrative overhead. However, you must consider the following before agreeing to an acquisition. Valuations and Deal Structuring Acquisitions of independent practices are typically structured around enterprise value multiples of Earnings Before Interest, Taxes, Depreciation, and Amortisation (EBITDA): Valuations are often influenced by factors such as specialty, recurring patient revenue, growth prospects, concentration risk, and the degree of reliance on the founding doctor. Market valuation multiples can vary significantly depending on the circumstances of each transaction. Cash-Equity Split: Standard deal terms involve an upfront cash payout of 60% to 70%, with the remaining 30% to 40% rolled over into equity in the parent company. This rollover aligns incentives for future exit events (e.g., IPO or secondary buyouts). Service Conditions and Lock-In Covenant Large groups are looking at acquiring patient goodwill and clinical continuity rather than just physical assets. Consequently, the sale terms normally include strict personal service conditions: Employment Lock-Ins: Expect mandatory 3-to-5-year employment contracts requiring the founding doctor to facilitate a smooth transition. Non-Compete Restrictive Covenants: Non-Compete Restrictive Covenants: Contracts include geographic and temporal non-compete clauses restricting doctors from practising independently within a specified radius in Singapore for several years post-resignation. Management Fees and Overhead Synergies While group integration provides access to corporate insurance panels, group procurement discounts, and centralised HR/HCSA compliance, it may also introduce new cost structures: Management Service Costs (MSC): Corporate groups typically charge a top-line or overhead management fee (oAten 10% to 20%) to cover centralised overhead. Margin Impact: Practice owners must evaluate whether economies of scale and increased patient volume oset the management fee’s impact on net operating margins. 3. Capital Diversification—External Assets and Adjacent Ventures For clinic owners looking to build wealth independently of their personal clinical hours, deploying profits into external assets offers a viable pathway to diversify risk. Investment Vehicle Strategic Rationale Key Considerations & Risk Profile Commercial Medical Real Estate Strata-titled medical suites (e.g., Novena Medical Centre, Mount Elizabeth, & Gleneagles) provide capital appreciation, rental yield, and long-term protection against lease increases. High capital requirements, may take time to find tenants. Adjacent Lifestyle Businesses Medical spas, aesthetic centres, physiotherapy practices, and wellness/longevity centres Creates patient cross-referral opportunities and leverages existing brand equity in cash-pay markets. Requires distinct management capabilities and operational oversight, must adhere to Singapore Medical Council (SMC) Ethical Code and Ethical Guidelines⁸ to prevent improper commercial steering. HealthTech & Vertical Integration Diagnostic labs, specialised medical supply distribution, or digital health
IPO Listing in Singapore: A SME Roadmap
Resources IPO Listing in Singapore: A SME Roadmap By Medinex Specialist Centre Team April 26, 2026 By Medinex Team The Singapore IPO market has entered a “renaissance phase” since 2025—which saw 13 listings raise over S$2.5 billion— following a suite of reforms by the Singapore Stock Exchange (SGX) and the Monetary Authority of Singapore (MAS) to revitalise the local equity market.1 For Small and Medium Enterprises (SMEs) in healthcare sectors, these changes have significantly lowered barriers to entry and support for companies after they go public. These include: Direct Financial Incentives & Tax Breaks: 20% Corporate Income Tax Rebate for 5 years.1 Structuring & Regulatory Easing: Mainboard profit threshold lowered to S$10 million.1 Boosting Market Liquidity: S$5 billion Equity Market Development Programme (EQDP).1 Post-Listing Support: S$30 million “Value Unlock” Package.2 1. 5 Benefits of IPO Listing There are many tangible benefits to IPO listing as it serves as the springboard to propel smaller businesses in healthcare onto a larger playing field in both scale of operation as well as markets they serve. Here’s a summary of these considerations. Access to vast capital for growthThe most immediate and important advantage is access to vast amounts of capital from the public markets. Unlike a bank loan, this capital doesn’t require monthly interest payments and provides the funding for expansion plans that were previously out of reach. Enhanced reputation & visibilityBeing listed on a major exchange is a seal of approval, signaling to customers, vendors, and the general public that the company has met rigorous regulatory and financial standards. Attracting & retaining talentThe branding of a publicly listed entity makes it easier for the company to recruit and retain the “best and brightest”. Lower cost of capitalPublic companies often enjoy a lower cost of capital for future financing because they are considered more transparent, as their shares are liquid, and they are often viewed as less risky by lenders. This allows the firm to negotiate better interest rates on debt. Creating a stronger network of business collaboratorsBeyond just prestige, having a public valuation makes it significantly easier to engage in Mergers and Acquisitions (M&A). Using stock as a form of payment allows for strategic partnerships and acquisitions that can solidify a company’s position within its ecosystem. 2. 6 Practical Steps For A Successful IPO Journey Using ABC IPO Listing is a major step for any company, and it is important to engage consultants who can provide professional advice with practical experience across every step of the IPO journey. Medinex Specialist Centre is a one-stop consultancy with more than 20 years of experience helping healthcare service providers through our incorporation, accounting & tax services, HR and business consultancy. The following IPO roadmap is based on our professional experience, and it provides a glimpse into the IPO journey. Do speak to us if you require further professional insights. STEP 1: A ssess Readliness The “Golden Rule” for listing remains the three-year financial audit. Investors in 2026 are highly selective, favouring companies that demonstrate “quality growth” over “growth at all costs, meaning companies that adopt a sustainable growth mindset. STEP 2: B e clear of the strategic intent STEP 2: Be clear of the strategic intent Your company stakeholders (owners, directors, management) are clear on their objectives for IPO listing, whether it is for regional expansion, strategic investment for growth, future acquisitions, and others. Alignment among stakeholders on these goals provides a strong foundation and an important starting point for the IPO journey. STEP 3: C hoose between Mainboard or Catalist STEP 3: Choose between Mainboard or Catalist As of 2026, Singapore Exchange (SGX) operates a dual-board structure tailored to companies at during stages of growth. The primary dierences revolve around entry criteria (profitability vs. growth potential), the role of sponsors, and regulatory oversight. Feature Mainboard Catalist Target Company Established, profitable High-growth, SME High-growth, SME Financial Criteria Yes: S$10m+ pre-tax profit (latest year) OR S$150m+ Mkt Cap No minimum profit/track record Sponsor Requirement No (Issue Manager only) Yes (Mandatory Full Sponsor) Prospectus Filing Lodged with MAS Offer Document via Sponsor Approval Body MAS and SGX Sponsor and SGX Visibility/Investor Institutional (organisations such as pensions, hedge funds) & Retail (Individuals) Growth-focused/Retail (Individuals) STEP 4: D etermine the Platform costs STEP 4: Determine the Platform costs Many view IPO as being prohibitively expensive, but when grants are factored in, the costs are a lot more manageable than expected. Based on our estimation, the costs for a Catalist listing typically range between S$1.5 million and S$2.5 million, covering issue managers, legal fees, and auditing. However, the MAS-backed GEMS scheme (extended to 2028) co-funds up to 20% of listing expenses, capped at S$300,000.5 STEP 5: E xecute the Restructuring Roadmap STEP 5: Execute the Restructuring Roadmap Consolidation of Ownership (Legal and asset consolidation to form a single, clean vehicle for the IPO.) Professionalising governance (Appointment and training of two Independent Directors to ensure they understand their fiduciary duties under the new SGX RegCo rules.) Tax & Legal “Housekeeping” (IRAS compliance, Audit Readiness, Asset Segregation) STEP 6: F orm the Team Last but not least, you need to assemble the team of professionals to help you with the IPO Listing, which includes sponsors (if you are listing on catalist), legal advisors, auditors, bankers, etc. Our IPO consultants can guide you through the entire journey. Footnote: Source: https://www.mas.gov.sg/news/media-releases/2025/a-comprehensive-set-of-measures-to-strengthen-singapores-equities-market Source: https://www.mas.gov.sg/news/media-releases/2025/review-group-completes-equities-market-review Source: https://sbr.com.sg/markets-investing/exclusive/sgx-reforms-set-stage-20-ipos-in-2026 Source: https://datatracks.com/sg/blog/sgx-ipo-readiness-2026-cfo-compliance/ Source: https://www.aeilegal.com/tldr/singapore-ipos-financial-support-for-listing-on-the-singapore-exchange Medinex Specialist Centre is an established one-stop consultancy service with more than 20 years of experience in company incorporation, accounting & tax services, HR and business consultancy specialising in helping healthcare service providers. We understand the challenges and have the necessary expertise to provide the right solutions to overcome them. For further consultation, send us an email at contact@medinexsc.com.sg . Tags: Business GrowthCorporate GovernanceHealthcare SMEIPO ListingIPO ReadinessListing RoadmapMedical Business AdvisorySGX CatalistSGX MainboardSingapore IPO